April 26, 2017 2:12 PM ET

Life Sciences Tools and Services

Company Overview of Crown Bioscience, Inc.

Company Overview

Crown Bioscience, Inc., a preclinical CRO, provides drug discovery and development services to biotech and pharmaceutical partners focusing on oncology and metabolic disease therapeutic areas. The company’s proprietary HuPrime, HuKemia, HuBase, HuMark, HuTrial, and HuSignature platforms enable lead optimization and translational strategies to deliver clinical candidates. It offers oncology services, such as oncology databases, Ex vivo services, human surrogate trials, in vitro and in vivo services, preclinical formulations, translational research, and drug discovery services; and metabolic disease services, including in vivo and in vitro services, cardiovascular and metabolic disease (CVMD) ...

3375 Scott Boulevard

Suite 108

Santa Clara, CA 95054

United States

Founded in 2006





Key Executives for Crown Bioscience, Inc.

Chief Executive Officer
Co-Founder, President and Chief Strategy Officer
Age: 52
Chief Financial Officer
Age: 58
Chief Operating Officer
Age: 51
President of International Institute of Biomedical Research (IIBR) and Senior Vice President of Cardiovascular & Metabolic Diseases (CVMD) Research
Compensation as of Fiscal Year 2016.

Crown Bioscience, Inc. Key Developments

CrownBio Presents at Annual China Healthcare Investment Conference, Mar-29-2017 09:30 AM

CrownBio Presents at Annual China Healthcare Investment Conference, Mar-29-2017 09:30 AM. Venue: Shangri-La Pudong Hotel, Shanghai, China. Speakers: Qian Shi, VP, Oncology.

Crown Bioscience Announces the Promotion of Dr. Jayant Thatte to General Manager

Crown Bioscience a wholly-owned subsidiary of Crown Bioscience International announced the promotion of Dr. Jayant Thatte to General Manager, heading up the company's center of excellence in San Diego. Dr. Thatte is an immunologist with 20 years of research experience in both academia and industry, focusing on cancer, autoimmunity, inflammation and pain. As Director of R&D and Associate Director of Operations at Molecular Response, he led the pharmacology team for numerous client projects that significantly increased revenue growth for the company, which ultimately resulted in the acquisition of PDX business by Crown Bioscience.

Crown Bioscience Announces Expansion of Therapeutic Expertise into Inflammation; Appoints Joel Tocker as Executive Director, Head of Inflammation

Crown Bioscience announced the expansion of its services into a novel therapeutic area, launching an Inflammatory Disease Division. Following significant growth in 2016, and with increasing demand for its Translational, Immuno-Oncology, and Cardiovascular and Metabolic Disease services and models, CrownBio is expanding its offering to include Inflammation lead by the appointment of Dr. Joel Tocker as Executive Director, Head of Inflammation. Tocker brings significant experience in the field of Inflammation, having previously directed the preclinical development of molecules targeting autoimmune, inflammatory, and respiratory disease at Janssen and lead projects targeting immune regulatory molecules in inflammatory and pulmonary disease at Amgen.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Crown Bioscience, Inc., please visit www.crownbio.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.